ICD-10-CM Billable Code

J84.112

Idiopathic pulmonary fibrosis

Clinical Classification Guidelines

Inclusion Terms

  • Cryptogenic fibrosing alveolitis
  • Idiopathic fibrosing alveolitis

Medical Intelligence & Overview

Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease characterized by progressive scarring of the lung tissue. Over time, the thickening and stiffening of the tissue make it increasingly difficult for the lungs to work properly, resulting in decreased oxygen supply to the blood. The term 'idiopathic' indicates that the exact cause of the scarring is unknown. IPF is a form of interstitial lung disease and is considered a serious and potentially life-threatening condition that primarily affects middle-aged and older adults.

Causes & Symptoms

Clinical Causes: The exact cause of idiopathic pulmonary fibrosis remains unknown, but several factors may contribute to its development: - Genetic predisposition - Long-term exposure to environmental pollutants, such as dust, fumes, or mold - Smoking history - Occupational exposures to certain chemicals or asbestos - Certain viral infections - Age, with higher prevalence in older adults Despite these potential risk factors, most cases are classified as idiopathic, meaning no clear cause can be identified.

Key Symptoms: The progression of IPF leads to various symptoms, which often develop gradually, including: - Persistent dry cough - Shortness of breath, especially during physical activity - Fatigue and weakness - Unintentional weight loss - Chest discomfort or pain - Clubbing of fingers (enlargement of the tips of the fingers) Due to the progressive nature of the disease, these symptoms tend to worsen over time, significantly affecting daily activities and quality of life.

Diagnostic & Treatment

Diagnosis Path: Diagnosing IPF involves a combination of medical history, physical examination, and specialized tests: - Medical history review, including symptoms and potential exposure risks - Chest X-ray to identify lung abnormalities - High-resolution computed tomography (HRCT) scan for detailed images of lung tissue - Pulmonary function tests to assess lung capacity and function - Blood tests to rule out other causes of lung symptoms - Lung biopsy in some cases to examine tissue for characteristic fibrosis Since IPF shares features with other interstitial lung diseases, accurate diagnosis often requires careful analysis by a team of specialists.

Treatment Protocols: While there is no cure for idiopathic pulmonary fibrosis, several treatments aim to slow disease progression and improve quality of life: - Antifibrotic medications, such as nintedanib and pirfenidone, which can reduce lung scarring - Supplemental oxygen therapy to maintain adequate oxygen levels - Pulmonary rehabilitation programs to enhance stamina and overall lung health - Management of symptoms, including cough suppressants or medications for comorbid conditions - Lung transplantation in suitable candidates, which may offer a longer-term solution Early diagnosis and management are crucial for optimizing outcomes and improving daily functioning.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is J84.112 a billable ICD-10 code?
Yes, J84.112 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report J84.112?
Clinical documentation must specify the nature of Idiopathic pulmonary fibrosis and any associated comorbidities for accurate reporting.

Cite this Clinical Reference